266331 |
ID638189 |
MM/GBSA |
Completed |
2025-07-17 01:15:04 (UTC + 8 hours) |
266330 |
ID265895 |
MM/GBSA |
Completed |
2025-07-17 01:12:35 (UTC + 8 hours) |
266329 |
ID087356 |
MM/GBSA |
Completed |
2025-07-17 00:55:38 (UTC + 8 hours) |
266328 |
IL6olokizmab |
HawkDock |
Completed |
2025-07-17 03:02:25 (UTC + 8 hours) |
266327 |
ILBCanakizumab |
HawkDock |
Completed |
2025-07-17 02:55:31 (UTC + 8 hours) |
266326 |
IL6RTocilizumab |
HawkDock |
Completed |
2025-07-17 02:55:05 (UTC + 8 hours) |
266325 |
ILBCanakizumab |
HawkDock |
Completed |
2025-07-17 02:52:17 (UTC + 8 hours) |
266324 |
ID019768_model2 |
MM/GBSA |
Completed |
2025-07-17 00:17:32 (UTC + 8 hours) |
266323 |
ID019768_model1 |
MM/GBSA |
Completed |
2025-07-17 00:17:32 (UTC + 8 hours) |
266322 |
ILBCanakizumab |
HawkDock |
Completed |
2025-07-17 02:46:50 (UTC + 8 hours) |
266321 |
IL6RTocilizumab |
HawkDock |
Completed |
2025-07-17 02:45:25 (UTC + 8 hours) |
266320 |
IL6RTocilizumab |
HawkDock |
Completed |
2025-07-17 02:42:11 (UTC + 8 hours) |
266319 |
ID019768 |
HawkDock |
Completed |
2025-07-17 13:07:10 (UTC + 8 hours) |
266318 |
AGS_Test_orf6B |
HawkDock |
Completed |
2025-07-17 05:55:24 (UTC + 8 hours) |
266317 |
p1_model1 |
MM/GBSA |
Completed |
2025-07-16 23:36:07 (UTC + 8 hours) |
266316 |
ID885752 |
MM/GBSA |
Completed |
2025-07-16 23:35:07 (UTC + 8 hours) |
266315 |
MEVCwith1DLH |
MM/GBSA |
Completed |
2025-07-16 23:13:47 (UTC + 8 hours) |
266314 |
MEVCwith5I1B |
MM/GBSA |
Completed |
2025-07-16 23:10:04 (UTC + 8 hours) |
266313 |
MEVCwith1I1Y |
MM/GBSA |
Completed |
2025-07-16 23:00:33 (UTC + 8 hours) |
266312 |
p1 |
HawkDock |
Completed |
2025-07-17 03:56:04 (UTC + 8 hours) |